On September 30, the iGReD had the pleasure of hosting the award ceremony for the Bristol Myers Squibb Foundation Prize, presented to Drs. Pierre Val and Alisson Voisin for their project entitled “Immunotherapy for Adrenocortical Carcinoma: A New Therapeutic Hope.”

This ambitious project aims to develop new immunotherapy strategies to improve the management of adrenocortical carcinoma, a rare and particularly aggressive tumor.

The prize was presented by Jean-Michel Béhier, Medical Director at Bristol Myers Squibb and member of the Foundation’s Board of Directors.

The iGReD warmly congratulates the awardees and extends its sincere thanks to the Bristol Myers Squibb Foundation for its continued support of biomedical research.